Step right up and receive all the updates on alternative routes of administration to the oral and intravenous route. In this lively session the pharmacology of rectal, sublingual, topical, and subcutaneous routes of opioid therapy in the setting of palliative care will be discussed. For each...
Complex medication decisions are an integral part of treating patients with pain and palliative care. Pharmacists have a unique perspective on using these medications creatively and effectively. This session will flirt with tips and tricks on using medications appropriately for patients with chronic...
There’s a new oral formulation for opioid induced constipation and it falls under the class of the PAMORAs which are the peripherally acting mu-opioid receptor antagonists.
So far on the market we have methylnaltrexone which is subcutaneous, we have alvimopan which is oral but it causes heart...
Dr. Atayee overviews some recently approved medications for treatment of opioid-induced constipation, nausea from chemotherapy, and insomnia. Clinical evidence is scarce, but all bear further investigation.
This segment discusses the major pain conditions that affect patients with cancer, and that can be positively managed with a personalized approach to palliative care.
Dr. Walker is an assistant professor of pharmacy practice, and a practitioner in palliative care. This segment discusses topical and transdermal medications, indications for use, and their role in the therapeutic plan.
Because patients in palliative care are often on so many medications, the clinical picture’s always changing. Their organ function changes, they have low protein stores sometimes that affects the way drugs interact, and many patients have different distributions of enzymes. A lot of the major drug...
Dr. Walker is an assistant professor of pharmacy practice, and a practitioner in palliative care. Here, she discusses the issue of drug interactions in the palliative care setting.